Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin.

Holmberg, Leona A; Becker, Pamela S; Bensinger, William

Holmberg, Leona A; Becker, Pamela S; Bensinger, William.

Affiliation

Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, WA, USA.

Acta Haematol ; 137(3): 123-131, 2017.

Article in En | MEDLINE | ID: mdl-28355602

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Hematopoietic Stem Cell Transplantation; Multiple Myeloma/drug therapy; Multiple Myeloma/therapy; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Clarithromycin/administration & dosage; Combined Modality Therapy; Consolidation Chemotherapy/methods; Dexamethasone/administration & dosage; Disease Progression; Female; Humans; Immunologic Factors/administration & dosage; Lenalidomide; Male; Middle Aged; Neoplasms, Second Primary/etiology; Peripheral Nervous System Diseases/chemically induced; Thalidomide/administration & dosage; Thalidomide/analogs & derivatives; Transplantation, Autologous; Treatment Outcome

Key words

Autologous hematopoietic stem cell transplantation; BLT-D; BiRd; Posttransplant therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Multiple Myeloma Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Acta Haematol Year: 2017 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google